Search results for "VALUATION"

showing 10 items of 2494 documents

A scaling-up strategy supporting the expansion of integrated care: a study protocol

2019

Purpose To ensure that more people will benefit from integrated care initiatives, scaling-up of successful initiatives is the way forward. However, new challenges present themselves as knowledge on how to achieve successful large-scale implementation is scarce. The EU-funded project SCIROCCO uses a step-based scaling-up strategy to explore what to scale-up, and how to scale-up integrated care initiatives by matching the complementary strengths and weaknesses of five European regions involved in integrated care. The purpose of this paper is to describe a multi-method evaluation protocol designed to understand what factors influence the implementation of the SCIROCCO strategy to support the …

Occupational therapyProtocol (science)medicine.medical_specialtyHealth (social science)Implementation fidelityProcess managementPublic AdministrationSociology and Political ScienceComputer science030503 health policy & servicesIntegrated careIntegrated care03 medical and health sciences0302 clinical medicineImplementation fidelityScaling-upmedicine030212 general & internal medicine0305 other medical scienceEvaluation protocolRealist evaluation
researchProduct

Wykorzystanie ram jakości M.J. Epplera do ewaluacji jakości informacji serwisów internetowych PWSZ

2019

The article presents the evaluation of information quality on the websites of the State Higher Vocational Schools (PWSZ) in Poland. The information quality framework proposed by M.J. Eppler was adopted as a diagnostic tool to identify gaps in information quality. The assessment was conducted from the user's perspective. Firstly, the ranking of the PWSZ sites in Poland was created. Secondly, the criteria for the quality of information in the website infrastructure were analysed. The conclusions result in a statement that most websites demonstrate a low level of information quality. The scope of synthetic measures ranges from 60.0% to 90.8% which indicates a wide variation in the information …

Ocena jakościJakość informacjiResearch resultsWebsiteSerwis internetowyWyniki badańEvaluationInformation qualityEwaluacjaQuality assessmentPrzegląd Organizacji
researchProduct

Aesthetic perception of single implants placed in the anterior zone. A cross-sectional study

2016

Background: Several aesthetic indexes have been described to assess implant aesthetics. The aim of this study was to compare the aesthetic assessment made by dental professionals and students of single-tooth implants placed in the upper incisors. Material and Methods: A cross-sectional survey study using a subjective questionnaire to assess the aesthetics in 3 implant supported single-tooth cases in the anterior maxilla was performed. The interviewed subjects were divided into 4 groups: dentists with experience in implant treatment, dentists without experience in implants and 3rd and 5th year dental students. The questionnaire consisted of 2 visual analogue scales (VAS) to evaluate aestheti…

Odontologia estèticaCross-sectional studymedicine.medical_treatmentDentistryOdontologíaEsthetics DentalMedical care evaluation050105 experimental psychologyCrown (dentistry)Dental aesthetic03 medical and health sciences0302 clinical medicinePatient satisfactionstomatognathic systemCronbach's alphaMaxillaHumansMedicine0501 psychology and cognitive sciencesGeneral DentistryCrownsImplants dentalsbusiness.industryResearchDental Implantation Endosseous05 social sciencesDental prosthesisDental implantsReproducibility of Results030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesCross-Sectional StudiesTreatment OutcomeOtorhinolaryngologyPatient SatisfactionMaxillaUNESCO::CIENCIAS MÉDICASSurgeryDental Prosthesis Implant-SupportedImplantOral SurgerybusinessImplant supportedAvaluació de l'assistència mèdica
researchProduct

Erratum to: Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty

2016

Background Frailty is highly prevalent in elderly people. While significant progress has been made to understand its pathogenesis process, few validated questionnaire exist to assess the multidimensional concept of frailty and to detect people frail or at risk to become frail. The objectives of this study were to construct and validate a new frailty-screening instrument named Frailty Groupe Iso-Ressource Evaluation (FRAGIRE) that accurately predicts the risk for frailty in older adults. Methods A prospective multicenter recruitment of the elderly patients was undertaken in France. The subjects were classified into financially-helped group (FH, with financial assistance) and non-financially …

Older personGerontologyRehabilitationFrailtybusiness.industryGeriatrics gerontologymedicine.medical_treatmentPublished ErratumMEDLINEEvaluation toolLoss of autonomy03 medical and health sciencesElderly0302 clinical medicinemedicine030212 general & internal medicineGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryResearch ArticleBMC Geriatrics
researchProduct

Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.

1990

Abstract purpose: A phase Ib/II clinical study was undertaken to assess the efficacy of recombinant human (rh) granulocyte-macrophage colony-stimulating (GM-CSF) factor in attenuating neutropenia and associated morbidity caused by high-dose anticancer chemotherapy administered in the presence or absence of autologous bone marrow support. patients and methods: Twenty-two patients with various solid tumors and lymphoid neoplasias were treated with a single daily subcutaneous dose of rh GM-CSF (250/μg/m 2 ) 48 hours after receiving a second cycle of highly myelotoxic chemotherapy for a period of 10 days. Within-subject comparisons on neutropenia-related clinical and laboratory variables were m…

OncologyAdultMalemedicine.medical_specialtyNeutropeniaTime FactorsAdolescentmedicine.drug_classNeutrophilsmedicine.medical_treatmentAntibioticsNeutropeniaLeukocyte CountColony-Stimulating FactorsBone MarrowInternal medicineNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansIn patientGrowth SubstancesAgedBone Marrow TransplantationChemotherapybusiness.industryCancerGranulocyte-Macrophage Colony-Stimulating FactorGeneral MedicineMiddle AgedAutologous bonemedicine.diseaseRecombinant ProteinsAnti-Bacterial AgentsGranulocyte macrophage colony-stimulating factorImmunologyToxicityDrug EvaluationFemalebusinessmedicine.drugAgranulocytosisThe American journal of medicine
researchProduct

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with epcampositive relapsed or refractory advanced-stage breast…

2012

Background: Targeted therapy options in HER2-negative breast cancer are limited. This open-label, multicenter phase IB dose-escalation trial was conducted to determine safety, tolerability, and antitumor activity of a combination of docetaxel (Taxotere) and increasing doses of adecatumumab, a human IgG1 antibody targeting epithelial cell adhesion molecule (EpCAM), in EpCAM-positive relapsed or primary refractory advanced-stage breast cancer. Patients and methods: Patients pretreated with up to four prior chemotherapy regimens received increasing adecatumumab doses either every 3 weeks (q3w) or weekly (qw) combined with docetaxel (100 mg/m 2 q3w). Primary end points were safety and tolerabil…

OncologyAdultmedicine.medical_specialtyMedizinBreast NeoplasmsDocetaxelAntibodies Monoclonal HumanizedDrug Administration ScheduleBreast cancerAdecatumumabLeukocytopeniaAntigens NeoplasmInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAgedbusiness.industryLiver NeoplasmsAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseEpithelial Cell Adhesion MoleculeMetastatic breast cancerSurgeryTreatment OutcomeOncologyDocetaxelTolerabilityResponse Evaluation Criteria in Solid TumorsDrug Resistance NeoplasmFemaleTaxoidsBreast diseaseNeoplasm Recurrence LocalbusinessCell Adhesion MoleculesLeukocyte Disordersmedicine.drug
researchProduct

A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer

2020

1024 Background: AZD9833 is an oral selective estrogen receptor (ER) antagonist and degrader (SERD) that has shown antitumor efficacy in a range of preclinical models of breast cancer. Methods: SERENA-1 (NCT03616587) is an ongoing Phase 1, open-label study in pre- and post-menopausal women, after ≥1 endocrine therapy and ≤2 prior chemotherapies for ER+ HER2- advanced breast cancer (ABC). The primary objective is to determine the safety and tolerability of AZD9833 once daily (QD), with dose-limiting toxicities (DLTs) in 28d defining the maximum tolerated dose. Secondary objectives include pharmacokinetics and anti-tumor response. Pharmacodynamic (PD) analysis includes ER modulation in paire…

OncologyCancer Researchmedicine.medical_specialtyAdvanced breastClinical Trials and Supportive ActivitiesEstrogen receptor32 Biomedical and Clinical Sciences6 Evaluation of treatments and therapeutic interventions03 medical and health sciences0302 clinical medicineBreast cancerClinical ResearchInternal medicineBreast CancerDose escalationMedicineCancerbusiness.industryAntagonistHER2 negativeCancermedicine.disease3211 Oncology and CarcinogenesisOncology030220 oncology & carcinogenesis6.1 Pharmaceuticalsbusiness030215 immunology
researchProduct

Endocrine and Clinical Evaluation of 107 Patients With Advanced Prostatic Carcinoma Under Long-Term Pernasal Buserelin or Intramuscular Decapeptyl De…

1988

Three major assumptions emerged from these clinical and endocrine long-term studies. First, buserelin, given pernasally in the conventional doses, and Decapeptyl microcapsules administered intramuscularly in 5-week intervals are equally effective in terms of their long-term castration effect in previously untreated patients with prostatic carcinoma. However, Decapeptyl causes complete LH and subsequent testosterone down-regulation 1 week earlier than buserelin. Furthermore, this treatment is more convenient, and the compliance is better. Both LHRH analogues are equally well tolerated. Second, in groups of prostate cancer patients with far advanced disease treated with palliative intention, …

OncologyCancer Researchmedicine.medical_specialtybusiness.industryUrologymedicine.diseaseBuserelinchemistry.chemical_compoundProstate cancerCastrationOncologychemistryInternal medicineCarcinomaMedicineEndocrine systembusinessClinical evaluationDecapeptyl DepotTestosteronemedicine.drugAmerican Journal of Clinical Oncology
researchProduct

Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs)

2017

Liquid biopsy is considered a valid strategy to improve patients’ selection and treatment monitoring in clinical practice. Indeed Circulating Tumor Cells (CTCs) represent an important component of liquid biopsy and their clinical evaluation is becoming fundamental for a better patients’ stratification. Several techniques have been developed for CTCs isolation and enrichment and in this chapter we provide an updated overview of the main strategies that can be used.

OncologyClinical Practicemedicine.medical_specialtyCirculating tumor cellbusiness.industryInternal medicineMedicineLiquid biopsybusinessClinical evaluationCirculating Tumor CellsTreatment monitoring
researchProduct

A multilocus technique for risk evaluation of patients with neuroblastoma.

2011

Abstract Purpose: Precise and comprehensive analysis of neuroblastoma genetics is essential for accurate risk evaluation and only pangenomic/multilocus approaches fulfill the present-day requirements. We present the establishment and validation of the PCR-based multiplex ligation-dependent probe amplification (MLPA) technique for neuroblastoma. Experimental Design: A neuroblastoma-specific MLPA kit was designed by the SIOP Europe Neuroblastoma Biology Committee in cooperation with MRC-Holland. The contained target sequences cover 19 chromosomal arms and reference loci. Validation was performed by single locus and pangenomic techniques (n = 174). Dilution experiments for determination of min…

OncologyGenetic MarkersCancer Researchmedicine.medical_specialtyConcordanceBioinformaticsRisk AssessmentNeuroblastoma cellNeuroblastomaRisk groupsLimit of DetectionInternal medicineNeuroblastomamedicineComputer GraphicsHumansMultiplexMultiplex ligation-dependent probe amplificationOncogene ProteinsN-Myc Proto-Oncogene Proteinbusiness.industryGene AmplificationNuclear Proteinsmedicine.diseaseDoenças GenéticasRisk evaluationOncologyMolecular Diagnostic TechniquesGenetic markerGenetic LociMutationbusinessClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct